clinical trial · NCT04057131
FIRAZYR General Drug Use-Results Survey (Japan)
Shire·—·completed·n = 179
Hereditary Angioedema (HAE)Firazyr
brief summary
The objectives of this survey are to collect data to report the safety and efficacy of Firazyr (Icatibant acetate) in the post-marketing phase in participants diagnosed with Hereditary Angioedema (HAE).
started
Nov 20, 2018
primary completion
Jul 29, 2024
completion
Jul 29, 2024
last updated
Feb 21, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol